Tag: Clinical
-
Dr Hanan H. Balkhy Launches Candidacy for WHO Director-General, Pledges "A WHO the World Can Count On"
Nominated by the Kingdom of Saudi ArabiaA physician trained in Saudi Arabia and the United States, with more than 30 years of experience spanning clinical medicine, academic research and international public health leadershipWHO Regional Director for the Eastern Mediterranean sets out a three-part p…
-
PT Prodia Diacro Laboratories Receives Frost & Sullivan's 2026 Southeast Asian Contract Research Organization Customer Value Leadership Recognition for Customer-Centric Clinical Research Excellence
Prodia the CRO is recognized for its reliable, integrated clinical research ecosystem, customer-centric delivery model, and commitment to quality, innovation, and long-term sponsor value across Southeast Asia.SAN ANTONIO, Sept. 8, 2026 /PRNewswire/ — Frost & Sullivan is pleased to announce that…
-
Amwell Receives Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition for Technology-Enabled Care Platforms
Amwell® is transforming virtual care delivery through its unified Amwell Platform, combining interoperability, clinical integration, and intelligent orchestration to improve access, efficiency, and outcomes.SAN ANTONIO, Sept. 5, 2026 /PRNewswire/ — As healthcare organizations move beyond fragmented…
-
AtomVie Global Radiopharma Celebrates the Grand Opening of its New State-of-the-Art Radiopharmaceutical Manufacturing Facility in Hamilton, Ontario
HAMILTON, ON, Sept. 4, 2026 /PRNewswire/ – AtomVie Global Radiopharma (AtomVie), a leading global Contract Development and Manufacturing Organization (CDMO) in the radiopharmaceutical industry, today celebrated the Grand Opening of its new purpose-built, state-of-the-art manufacturing facility at 10…
-
ZEISS elevates ophthalmic workflows at ESCRS with new surgical and digital advancements
ZEISS Medical Technology will showcase new clinical and digital workflow innovations at ESCRS, including:New ZEISS IOL offering is the world’s first bitoric hydrophobic monofocal IOL with a non-constant asphericity profile design to treat cataracts while simultaneously correcting astigmatism.The EVA…
-
FutureCeuticals , Inc. (FC) and Aura Scientific Resolve Coffee Fruit Patent Dispute, Recognize FC Patent Rights, and Initiate Seamless Transition to CognatiQ®
MOMENCE, Ill., Sept. 3, 2026 /PRNewswire/ — FutureCeuticals, Inc. (FC) and Aura Scientific (Aura) are pleased to announce the resolution of FutureCeuticals’ patent and trademark suit related to Aura’s NeuroRush® ingredient and FutureCeuticals’ whole coffee fruit extract marketed under the tradename…
-
NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury
Round led by Neurimmune and Pureos, with participation from existing and new investors; complemented by non-dilutive funding from the Swiss Paraplegic Foundation and Wings for Life – Spinal Cord Research Foundation.SCHLIEREN, Switzerland, Sept. 2, 2026 /PRNewswire/ — NovaGo Therapeutics AG, a clini…
-
BTL Establishes New Laser Division and Introduces EXOLASE ONE® – The World's First Fused Erbium Laser
Proprietary technology fuses multiple wavelengths into a single beam to set a new standard of care in laser facial rejuvenation.PRAGUE, Sept. 2, 2026 /PRNewswire/ — BTL, a global leader in advanced energy-based medical and aesthetic technologies, today announced a major milestone in its corporate h…
-
Suki Named a Transformational Innovation Leader in Ambient Clinical Intelligence by Frost & Sullivan
2026 recognition highlights Suki’s innovation, clinical quality and measurable impact as Ambient Clinical Intelligence expands across the enterpriseSAN ANTONIO, Sept. 1, 2026 /PRNewswire/ — Suki, the leader in Ambient Clinical Intelligence (ACI), has been recognized by Frost & Sullivan with its…
-
Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients
PALMA DE MALLORCA, Spain, July 24, 2026 /PRNewswire/ — Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV) in the company’s Phase 2b/3 clinical trial of its …
Latest News
About the Author
Your reliable go-to for precise and up-to-date information!
We are dedicated to accuracy, impartiality, and providing news as it unfolds, earning the trust of a wide audience. Keep up with real-time updates on the latest events and trends.